Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2026-05-21 @ 12:15 PM
Study NCT ID:
NCT02446093
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-08
First Post:
2015-04-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma
Sponsor:
Organization: